Globus Medical shareholders approve share issuance for NuVasive merger

Globus Medical (GMED) announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive (NUVA). As previously announced, under the terms of the merger agreement, Globus Medical will issue 0.75 of a share of Globus Medical Class A common stock in exchange for each share of NuVasive common stock owned at the closing of the transaction. "Globus Medical shareholders showed an overwhelming level of support for this merger," said Dan Scavilla, president and CEO of Globus Medical. "Globus Medical and NuVasive are committed to providing innovative technologies and industry leading clinical support to help surgeons and healthcare providers deliver continually improving care. Our combined company will have one of the most comprehensive offerings of musculoskeletal solutions and enabling technologies to help surgeons treat their patients. The combined company will have over 5,000 employees who are relentlessly focused on improving patient lives." NuVasive separately announced that at its special meeting of shareholders held earlier today its shareholders voted to approve the adoption of the Company’s merger agreement with "strong support for NuVasive’s combination with Globus Medical."